Почетна › Рак на жолчните патишта › Флорида
Клинички испитувања за Рак на жолчните патишта во Флорида
14 студии за Рак на жолчните патишта бараат учесници на локации во Флорида.
Градови во Флорида
Официјален текст на студијата (англиски)
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06760819A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Moffitt Cancer Center Magnolia Campus (Site 123), Tampa
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07265674A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Research Site, Gainesville
- Research Site, Jacksonville
- Research Site, Miami
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- University of Florida College of Medicine ( Site 0281), Gainesville
- Mount Sinai Cancer Center ( Site 0287), Miami Beach
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06428409Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- AdventHealth Hematology and Oncology, Orlando
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT06282575Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Miami, Miami
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Orlando
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
Се регрутираФаза 1/2
Возраст од 18 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT07038343Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Research Site, Fort Myers
- Research Site, Jacksonville
- Research Site, St. Petersburg
- и уште 2
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 19.8.2026 · NCT06467357A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT05592626D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
- Mount Sinai Medical Center, Miami Beach
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT06622057A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Miami Hospital and Clinics, Miami
Се регрутираФаза 2
Возраст 8 и постари · Сите полови · Ажурирано 27.7.2026 · NCT05503797A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07458347Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT06239194Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics), Miami
- Moffitt Cancer Center, Tampa
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.4.2026 · NCT05733598Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.